ADPT
Adaptive Biotechnologies Corporation Common Stock
stockNASDAQ
we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca. our world class scientists have invented a patent-pending technology that combines advances in high-throughput sequencing with state-of-the-art computer infrastructure to provide an in-depth analysis of the t- and b-cell repertoire, a specific and important part of the immune system. this information is driving the r&d community to support the fights against cancer, auto-immune disease, and much, much more. we're often asked to describe our company culture. it is very easy ... we're a hard working group of top-notch individuals who are passionate about wanting to make a difference in the world. we know our employees are our most valuable asset, and every employee's contribution is appreciated. open communication and collaboration are always encouraged in every interaction throughout the organization. we have high expectations of ourselves, and
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 27.98 | 2026-11-06 | +3.82% | 3.584 |
| 1M | 25.28 | 2026-10-13 | +14.91% | 1.543 |
| 3M | 24.46 | 2026-08-13 | +18.77% | 1.209 |
| 6M | 13.13 | 2026-05-13 | +121.25% | 1.539 |
| 1Y | 14.14 | 2025-11-13 | +105.45% | 1.554 |
| 2Y | 5.85 | 2024-11-13 | +396.58% | — |
| 5Y | 33.21 | 2021-11-12 | -12.53% | 2.012 |
Adaptive Biotechnologies Corporation Common Stock (NASDAQ:ADPT) stock price today is $29.05, and today's volume is 2,063,762. ADPT is down 1.459% today. The 30 day average volume is 2.15M. ADPT market cap is $4.70B with 161.88M shares outstanding.